drugset / Trial / NCT01246908
Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if CX157 is effective and safe in patients with treatment of treatment resistant depression over six weeks of treatment.
Timeline
- Start
- 2010-11
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CX157 | Small molecule | 125 mg | — |
Indications
No indication recorded.